Embecta (NASDAQ:EMBC) Hits New 1-Year Low – Here’s What Happened

Embecta Corp. (NASDAQ:EMBC) hit a new 52-week low during trading on Thursday . The company traded as low as $8.78 and last traded at $9.00, with a volume of 794567 shares changing hands. The stock had previously closed at $9.09.

Analyst Upgrades and Downgrades

EMBC has been the subject of a number of recent research reports. BTIG Research reissued a “buy” rating and set a $25.00 price target on shares of Embecta in a research report on Friday, February 6th. Wall Street Zen upgraded shares of Embecta from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 7th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Embecta in a report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $18.50.

Embecta Stock Down 1.0%

The company has a market capitalization of $532.98 million, a PE ratio of 3.80 and a beta of 1.10. The firm has a 50-day moving average of $10.91 and a two-hundred day moving average of $12.65.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings data on Thursday, February 5th. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.04. The business had revenue of $261.20 million for the quarter, compared to analysts’ expectations of $258.07 million. Embecta had a net margin of 12.92% and a negative return on equity of 26.66%. The business’s revenue was down .3% on a year-over-year basis. During the same quarter last year, the company earned $0.65 EPS. Embecta has set its FY 2026 guidance at 2.800-3.00 EPS. Equities analysts predict that Embecta Corp. will post 2.85 EPS for the current fiscal year.

Embecta Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Friday, February 27th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 6.7%. The ex-dividend date is Friday, February 27th. Embecta’s dividend payout ratio (DPR) is currently 25.32%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Laurel Wealth Advisors LLC grew its position in shares of Embecta by 754.3% during the 2nd quarter. Laurel Wealth Advisors LLC now owns 1,871 shares of the company’s stock valued at $193,000 after acquiring an additional 1,652 shares during the period. Larson Financial Group LLC raised its holdings in Embecta by 368.6% in the 3rd quarter. Larson Financial Group LLC now owns 2,001 shares of the company’s stock worth $28,000 after purchasing an additional 1,574 shares during the period. Wexford Capital LP acquired a new position in Embecta in the 3rd quarter worth about $94,000. Tower Research Capital LLC TRC boosted its position in Embecta by 542.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,371 shares of the company’s stock worth $71,000 after purchasing an additional 6,224 shares in the last quarter. Finally, iSAM Funds UK Ltd acquired a new stake in Embecta in the third quarter valued at approximately $115,000. Institutional investors and hedge funds own 93.83% of the company’s stock.

About Embecta

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.